
LINK . SPRINGER . COM {
}
Title:
Refractory Colitis Following Anti-CTLA4 Antibody Therapy: Analysis of Mucosal FOXP3+ T Cells | Digestive Diseases and Sciences
Description:
Ipilimumab is a humanized antibody to CTLA4 and is used to treat cancers refractory to conventional treatment. We treated 21 patients with refractory melanoma or prostate cancer with anti-CTLA4 antibody (ipilimumab), with subsequent development of significant colitis in nine cases. Two of these nine did not respond rapidly to high-dose (2 mg kg−1 day−1) glucocorticoids or infliximab. They required additional immunosuppression, and one ultimately died of opportunistic infection, representing a more refractory course than has previously been described complicating ipilimumab therapy. Both patients had received radiation to the pelvis for prostate cancer less than 1 year prior to receiving ipilimumab. We performed immunohistochemical analysis of colon biopsies from ipilimumab recipients to determine if colitis correlates with depletion of intramucosal FOXP3+ regulatory T cells (Tregs), which normally express CTLA4. However, we found no evidence of FOXP3+ T cell depletion in any of the nine patients who developed colitis.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We see no obvious way the site makes money.
While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.
Keywords {🔍}
article, cancer, pubmed, google, scholar, cas, ctla, patients, cells, antigen, ipilimumab, regulatory, cytotoxic, colitis, antibody, blockade, antictla, foxp, melanoma, usa, privacy, cookies, content, research, refractory, lord, prostate, access, seattle, analysis, publish, search, james, hackman, john, thompson, celestia, higano, mcdonald, disease, subjects, human, lymphocyteassociated, trial, clin, function, personal, data, information, log,
Topics {✒️}
acute graft-versus-host disease month download article/chapter anti-ctla4 antibody therapy regulatory t-cell biology bristol-myers squibb company cytotoxic t-lymphocyte antigen-4 article digestive diseases hormone-refractory prostate cancer anti-ctla4 antibody full article pdf cytotoxic t-lymphocyte privacy choices/manage cookies inflammatory bowel disease human anti-ctla-4 cancer response due cancer vaccine failure complicating ipilimumab therapy european economic area required additional immunosuppression resected stages iii control intestinal inflammation regulatory properties isolated health ai48779 ai007411 gideon steinbach & george clin cancer res intramucosal foxp3+ regulatory related subjects conditions privacy policy treat cancers refractory 2 mg kg−1 day−1 personal financial relationships ann surg oncol yang jc accepting optional cookies phan gq multiple melanoma peptides performed immunohistochemical analysis check access instant access article log journal finder publish author information authors article cite prostate cancer antibody blockade refractory colitis cd4+ cd25+ regulatory article lord human nomenclature anti-ctla-4
Questions {❓}
- Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?
Schema {🗺️}
WebPage:
mainEntity:
headline:Refractory Colitis Following Anti-CTLA4 Antibody Therapy: Analysis of Mucosal FOXP3+ T Cells
description:Ipilimumab is a humanized antibody to CTLA4 and is used to treat cancers refractory to conventional treatment. We treated 21 patients with refractory melanoma or prostate cancer with anti-CTLA4 antibody (ipilimumab), with subsequent development of significant colitis in nine cases. Two of these nine did not respond rapidly to high-dose (2 mg kg−1 day−1) glucocorticoids or infliximab. They required additional immunosuppression, and one ultimately died of opportunistic infection, representing a more refractory course than has previously been described complicating ipilimumab therapy. Both patients had received radiation to the pelvis for prostate cancer less than 1 year prior to receiving ipilimumab. We performed immunohistochemical analysis of colon biopsies from ipilimumab recipients to determine if colitis correlates with depletion of intramucosal FOXP3+ regulatory T cells (Tregs), which normally express CTLA4. However, we found no evidence of FOXP3+ T cell depletion in any of the nine patients who developed colitis.
datePublished:2009-06-09T00:00:00Z
dateModified:2009-06-09T00:00:00Z
pageStart:1396
pageEnd:1405
sameAs:https://doi.org/10.1007/s10620-009-0839-8
keywords:
Ipilimumab
CTLA4
FOXP3
Colitis
Gastroenterology
Hepatology
Oncology
Transplant Surgery
Biochemistry
general
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-009-0839-8/MediaObjects/10620_2009_839_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-009-0839-8/MediaObjects/10620_2009_839_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-009-0839-8/MediaObjects/10620_2009_839_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-009-0839-8/MediaObjects/10620_2009_839_Fig4_HTML.gif
isPartOf:
name:Digestive Diseases and Sciences
issn:
1573-2568
0163-2116
volumeNumber:55
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:James D. Lord
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Benaroya Research Institute at Virginia Mason
address:
name:Benaroya Research Institute at Virginia Mason, Seattle, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Robert C. Hackman
affiliation:
name:University of Washington
address:
name:Department of Pathology, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
type:Person
name:Amanda Moklebust
affiliation:
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
type:Person
name:John A. Thompson
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
type:Person
name:Celestia S. Higano
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
type:Person
name:Deborah Chielens
affiliation:
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
type:Person
name:Gideon Steinbach
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
type:Person
name:George B. McDonald
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Refractory Colitis Following Anti-CTLA4 Antibody Therapy: Analysis of Mucosal FOXP3+ T Cells
description:Ipilimumab is a humanized antibody to CTLA4 and is used to treat cancers refractory to conventional treatment. We treated 21 patients with refractory melanoma or prostate cancer with anti-CTLA4 antibody (ipilimumab), with subsequent development of significant colitis in nine cases. Two of these nine did not respond rapidly to high-dose (2 mg kg−1 day−1) glucocorticoids or infliximab. They required additional immunosuppression, and one ultimately died of opportunistic infection, representing a more refractory course than has previously been described complicating ipilimumab therapy. Both patients had received radiation to the pelvis for prostate cancer less than 1 year prior to receiving ipilimumab. We performed immunohistochemical analysis of colon biopsies from ipilimumab recipients to determine if colitis correlates with depletion of intramucosal FOXP3+ regulatory T cells (Tregs), which normally express CTLA4. However, we found no evidence of FOXP3+ T cell depletion in any of the nine patients who developed colitis.
datePublished:2009-06-09T00:00:00Z
dateModified:2009-06-09T00:00:00Z
pageStart:1396
pageEnd:1405
sameAs:https://doi.org/10.1007/s10620-009-0839-8
keywords:
Ipilimumab
CTLA4
FOXP3
Colitis
Gastroenterology
Hepatology
Oncology
Transplant Surgery
Biochemistry
general
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-009-0839-8/MediaObjects/10620_2009_839_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-009-0839-8/MediaObjects/10620_2009_839_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-009-0839-8/MediaObjects/10620_2009_839_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10620-009-0839-8/MediaObjects/10620_2009_839_Fig4_HTML.gif
isPartOf:
name:Digestive Diseases and Sciences
issn:
1573-2568
0163-2116
volumeNumber:55
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:James D. Lord
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Benaroya Research Institute at Virginia Mason
address:
name:Benaroya Research Institute at Virginia Mason, Seattle, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Robert C. Hackman
affiliation:
name:University of Washington
address:
name:Department of Pathology, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
type:Person
name:Amanda Moklebust
affiliation:
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
type:Person
name:John A. Thompson
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
type:Person
name:Celestia S. Higano
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
type:Person
name:Deborah Chielens
affiliation:
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
type:Person
name:Gideon Steinbach
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
type:Person
name:George B. McDonald
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Digestive Diseases and Sciences
issn:
1573-2568
0163-2116
volumeNumber:55
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
name:Benaroya Research Institute at Virginia Mason
address:
name:Benaroya Research Institute at Virginia Mason, Seattle, USA
type:PostalAddress
name:University of Washington
address:
name:Department of Pathology, University of Washington, Seattle, USA
type:PostalAddress
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:James D. Lord
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Benaroya Research Institute at Virginia Mason
address:
name:Benaroya Research Institute at Virginia Mason, Seattle, USA
type:PostalAddress
type:Organization
email:[email protected]
name:Robert C. Hackman
affiliation:
name:University of Washington
address:
name:Department of Pathology, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
name:Amanda Moklebust
affiliation:
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
name:John A. Thompson
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
name:Celestia S. Higano
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
name:Deborah Chielens
affiliation:
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
name:Gideon Steinbach
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
name:George B. McDonald
affiliation:
name:University of Washington
address:
name:Department of Medicine, University of Washington, Seattle, USA
type:PostalAddress
type:Organization
name:Fred Hutchinson Cancer Research Center
address:
name:Fred Hutchinson Cancer Research Center, Seattle, USA
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Medicine, University of Washington, Seattle, USA
name:Benaroya Research Institute at Virginia Mason, Seattle, USA
name:Department of Pathology, University of Washington, Seattle, USA
name:Fred Hutchinson Cancer Research Center, Seattle, USA
name:Fred Hutchinson Cancer Research Center, Seattle, USA
name:Department of Medicine, University of Washington, Seattle, USA
name:Fred Hutchinson Cancer Research Center, Seattle, USA
name:Department of Medicine, University of Washington, Seattle, USA
name:Fred Hutchinson Cancer Research Center, Seattle, USA
name:Fred Hutchinson Cancer Research Center, Seattle, USA
name:Department of Medicine, University of Washington, Seattle, USA
name:Fred Hutchinson Cancer Research Center, Seattle, USA
name:Department of Medicine, University of Washington, Seattle, USA
name:Fred Hutchinson Cancer Research Center, Seattle, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(100)
- Revenue of https://www.springernature.com/gp/authors
- Profit of https://link.springernature.com/home/
- How much money does https://order.springer.com/public/cart generate?
- How much cash flow does https://submission.springernature.com/new-submission/10620/3 have monthly?
- What's the monthly income of https://www.springernature.com/gp/librarians/licensing/agc/journals?
- Learn how profitable https://doi.org/10.1111/j.0105-2896.2006.00419.x is on a monthly basis
- How much revenue does https://doi.org/10.1111%2Fj.0105-2896.2006.00419.x generate?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16903911 earning monthly?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20CD28%20and%20cytotoxic%20T-lymphocyte%20antigen-4%20%28CTLA-4%29%20in%20regulatory%20T-cell%20biology&journal=Immunol%20Rev&doi=10.1111%2Fj.0105-2896.2006.00419.x&volume=212&pages=131-148&publication_year=2006&author=Sansom%2CDM&author=Walker%2CLS
- What's https://doi.org/10.1126/science.270.5238.985's gross income?
- What are the total earnings of https://doi.org/10.1126%2Fscience.270.5238.985?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7481803
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Lymphoproliferative%20disorders%20with%20early%20lethality%20in%20mice%20deficient%20in%20Ctla-4&journal=Science&doi=10.1126%2Fscience.270.5238.985&volume=270&pages=985-988&publication_year=1995&author=Waterhouse%2CP&author=Penninger%2CJM&author=Timms%2CE&author=Wakeham%2CA&author=Shahinian%2CA&author=Lee%2CKP?
- How profitable is https://doi.org/10.1002/cncr.23086?
- How much money does https://doi.org/10.1002%2Fcncr.23086 generate?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18000991?
- How much money does http://scholar.google.com/scholar_lookup?&title=Targeting%20cytotoxic%20T-lymphocyte%20antigen-4%20%28CTLA-4%29%3A%20A%20novel%20strategy%20for%20the%20treatment%20of%20melanoma%20and%20other%20malignancies&journal=Cancer&doi=10.1002%2Fcncr.23086&volume=110&pages=2614-2627&publication_year=2007&author=O%E2%80%99Day%2CSJ&author=Hamid%2CO&author=Urba%2CWJ generate?
- How much revenue does https://doi.org/10.1245/ASO.2005.03.536 generate?
- How much profit does https://doi.org/10.1245%2FASO.2005.03.536 make?
- What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16283570?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Tumor%20regression%20and%20autoimmunity%20in%20patients%20treated%20with%20cytotoxic%20T%20lymphocyte-associated%20antigen%204%20blockade%20and%20interleukin%202%3A%20A%20phase%20I%2FII%20study&journal=Ann%20Surg%20Oncol&doi=10.1245%2FASO.2005.03.536&volume=12&pages=1005-1016&publication_year=2005&author=Maker%2CAV&author=Phan%2CGQ&author=Attia%2CP&author=Yang%2CJC&author=Sherry%2CRM&author=Topalian%2CSL bring in?
- How much does https://doi.org/10.1073/pnas.1533209100 pull in?
- How much income does https://doi.org/10.1073%2Fpnas.1533209100 have?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12826605
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Cancer%20regression%20and%20autoimmunity%20induced%20by%20cytotoxic%20T%20lymphocyte-associated%20antigen%204%20blockade%20in%20patients%20with%20metastatic%20melanoma&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.1533209100&volume=100&pages=8372-8377&publication_year=2003&author=Phan%2CGQ&author=Yang%2CJC&author=Sherry%2CRM&author=Hwu%2CP&author=Topalian%2CSL&author=Schwartzentruber%2CDJ bring in?
- https://doi.org/10.1200/JCO.2005.01.128's financial summary
- How much does https://doi.org/10.1200%2FJCO.2005.01.128 net monthly?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15613700 have monthly?
- How much income does http://scholar.google.com/scholar_lookup?&title=Autoimmunity%20in%20a%20phase%20I%20trial%20of%20a%20fully%20human%20anti-cytotoxic%20T-lymphocyte%20antigen-4%20monoclonal%20antibody%20with%20multiple%20melanoma%20peptides%20and%20Montanide%20ISA%2051%20for%20patients%20with%20resected%20stages%20III%20and%20IV%20melanoma&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.01.128&volume=23&pages=741-750&publication_year=2005&author=Sanderson%2CK&author=Scotland%2CR&author=Lee%2CP&author=Liu%2CD&author=Groshen%2CS&author=Snively%2CJ have?
- Monthly income for https://doi.org/10.1200/JCO.2005.04.5716
- How much revenue does https://doi.org/10.1200%2FJCO.2005.04.5716 produce monthly?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16710025 makes per month
- Get to know http://scholar.google.com/scholar_lookup?&title=Enterocolitis%20in%20patients%20with%20cancer%20after%20antibody%20blockade%20of%20cytotoxic%20T-lymphocyte-associated%20antigen%204&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.04.5716&volume=24&pages=2283-2289&publication_year=2006&author=Beck%2CKE&author=Blansfield%2CJA&author=Tran%2CKQ&author=Feldman%2CAL&author=Hughes%2CMS&author=Royal%2CRE's earnings
- https://doi.org/10.1097/CJI.0b013e318156e47e income
- What's the financial outcome of https://doi.org/10.1097%2FCJI.0b013e318156e47e?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18049334's revenue stream
- How much profit does http://scholar.google.com/scholar_lookup?&title=Ipilimumab%20%28anti-CTLA4%20antibody%29%20causes%20regression%20of%20metastatic%20renal%20cell%20cancer%20associated%20with%20enteritis%20and%20hypophysitis&journal=J%20Immunother&doi=10.1097%2FCJI.0b013e318156e47e&volume=30&pages=825-830&publication_year=2007&author=Yang%2CJC&author=Hughes%2CM&author=Kammula%2CU&author=Royal%2CR&author=Sherry%2CRM&author=Topalian%2CSL make?
- What's the total monthly financial gain of https://doi.org/10.1158/1078-0432.CCR-06-1974?
- How much does https://doi.org/10.1158%2F1078-0432.CCR-06-1974 make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17289891 pull in?
- Find out how much http://scholar.google.com/scholar_lookup?&title=A%20pilot%20study%20of%20CTLA-4%20blockade%20after%20cancer%20vaccine%20failure%20in%20patients%20with%20advanced%20malignancy&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-1974&volume=13&pages=958-964&publication_year=2007&author=O%E2%80%99Mahony%2CD&author=Morris%2CJC&author=Quinn%2CC&author=Gao%2CW&author=Wilson%2CWH&author=Gause%2CB earns monthly
- How much does https://doi.org/10.1158/1078-0432.CCR-06-2318 bring in each month?
- How much profit does https://doi.org/10.1158%2F1078-0432.CCR-06-2318 generate?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17363537?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=A%20pilot%20trial%20of%20CTLA-4%20blockade%20with%20human%20anti-CTLA-4%20in%20patients%20with%20hormone-refractory%20prostate%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-06-2318&volume=13&pages=1810-1815&publication_year=2007&author=Small%2CEJ&author=Tchekmedyian%2CNS&author=Rini%2CBI&author=Fong%2CL&author=Lowy%2CI&author=Allison%2CJP generate?
- What is the monthly revenue of https://doi.org/10.1084/jem.192.2.295?
- How much revenue does https://doi.org/10.1084%2Fjem.192.2.295 produce monthly?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10899916
- How much profit does http://scholar.google.com/scholar_lookup?&title=Cytotoxic%20T%20lymphocyte-associated%20antigen%204%20plays%20an%20essential%20role%20in%20the%20function%20of%20CD25%28%2B%29CD4%28%2B%29%20regulatory%20cells%20that%20control%20intestinal%20inflammation&journal=J%20Exp%20Med&doi=10.1084%2Fjem.192.2.295&volume=192&pages=295-302&publication_year=2000&author=Read%2CS&author=Malmstrom%2CV&author=Powrie%2CF make?
- How much revenue does https://doi.org/10.1084/jem.192.2.303 produce monthly?
- How much money does https://doi.org/10.1084%2Fjem.192.2.303 make?
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10899917's earnings
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Immunologic%20self-tolerance%20maintained%20by%20CD25%28%2B%29CD4%28%2B%29%20regulatory%20T%20cells%20constitutively%20expressing%20cytotoxic%20T%20lymphocyte-associated%20antigen%204&journal=J%20Exp%20Med&doi=10.1084%2Fjem.192.2.303&volume=192&pages=303-310&publication_year=2000&author=Takahashi%2CT&author=Tagami%2CT&author=Yamazaki%2CS&author=Uede%2CT&author=Shimizu%2CJ&author=Sakaguchi%2CN?
- What's the profit of https://doi.org/10.1084/jem.193.11.1285?
- https://doi.org/10.1084%2Fjem.193.11.1285's financial summary
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11390435?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Identification%20and%20functional%20characterization%20of%20human%20CD4%28%2B%29CD25%28%2B%29%20T%20cells%20with%20regulatory%20properties%20isolated%20from%20peripheral%20blood&journal=J%20Exp%20Med&doi=10.1084%2Fjem.193.11.1285&volume=193&pages=1285-1294&publication_year=2001&author=Jonuleit%2CH&author=Schmitt%2CE&author=Stassen%2CM&author=Tuettenberg%2CA&author=Knop%2CJ&author=Enk%2CAH
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16982872 makes per month
- What's the income of http://scholar.google.com/scholar_lookup?&title=Blockade%20of%20CTLA-4%20on%20CD4%2B%20CD25%2B%20regulatory%20T%20cells%20abrogates%20their%20function%20in%20vivo&journal=J%20Immunol&volume=177&pages=4376-4383&publication_year=2006&author=Read%2CS&author=Greenwald%2CR&author=Izcue%2CA&author=Robinson%2CN&author=Mandelbrot%2CD&author=Francisco%2CL?
- How much profit does https://doi.org/10.1016/j.immuni.2004.06.017 make?
- How much revenue does https://doi.org/10.1016%2Fj.immuni.2004.06.017 produce monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15357951 bring in each month?
- What's http://scholar.google.com/scholar_lookup?&title=B7-1%20and%20B7-2%20selectively%20recruit%20CTLA-4%20and%20CD28%20to%20the%20immunological%20synapse&journal=Immunity&doi=10.1016%2Fj.immuni.2004.06.017&volume=21&pages=401-413&publication_year=2004&author=Pentcheva-Hoang%2CT&author=Egen%2CJG&author=Wojnoonski%2CK&author=Allison%2CJP's gross income?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6986319 gross monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20diagnostic%20accuracy%20of%20the%20rectal%20biopsy%20in%20acute%20graft-versus-host%20disease%3A%20A%20prospective%20study%20of%20thirteen%20patients&journal=Gastroenterology&volume=78&pages=764-771&publication_year=1980&author=Epstein%2CRJ&author=McDonald%2CGB&author=Sale%2CGE&author=Shulman%2CHM&author=Thomas%2CED net monthly?
- What's the income generated by https://citation-needed.springer.com/v2/references/10.1007/s10620-009-0839-8?format=refman&flavour=references each month?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=James%20D.%20Lord's revenue stream
- Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22James%20D.%20Lord%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Robert%20C.%20Hackman?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Robert%20C.%20Hackman%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en rake in every month?
- What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Amanda%20Moklebust's gross income?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Amanda%20Moklebust%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=John%20A.%20Thompson
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22John%20A.%20Thompson%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Celestia%20S.%20Higano?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Celestia%20S.%20Higano%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Deborah%20Chielens
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Deborah%20Chielens%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gideon%20Steinbach pull in?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gideon%20Steinbach%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=George%20B.%20McDonald's revenue stream
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22George%20B.%20McDonald%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- See how much https://s100.copyright.com/AppDispatchServlet?title=Refractory%20Colitis%20Following%20Anti-CTLA4%20Antibody%20Therapy%3A%20Analysis%20of%20Mucosal%20FOXP3%2B%20T%20Cells&author=James%20D.%20Lord%20et%20al&contentID=10.1007%2Fs10620-009-0839-8©right=Springer%20Science%2BBusiness%20Media%2C%20LLC&publication=0163-2116&publicationDate=2009-06-09&publisherName=SpringerNature&orderBeanReset=true makes per month
- How much does https://citation-needed.springer.com/v2/references/10.1007/s10620-009-0839-8?format=refman&flavour=citation gross monthly?
- Earnings of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- What's the income of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- What's https://www.springernature.com/gp/products's gross income?
- How much cash flow does https://www.springernature.com/gp/librarians have monthly?
- How much does https://www.springernature.com/gp/societies net monthly?
- Get to know https://www.springernature.com/gp/partners's earnings
- How much money does https://www.springer.com/ make?
- https://www.nature.com/'s revenue stream
- How much does https://www.biomedcentral.com/ pull in?
- What's the income of https://www.palgrave.com/?
- https://www.apress.com/ income
- How much income is https://www.springernature.com/gp/legal/ccpa earning monthly?
- What's the monthly money flow for https://www.springernature.com/gp/info/accessibility?
- What's the financial intake of https://support.springernature.com/en/support/home?
- Explore the financials of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
- What's the monthly income of https://www.springernature.com/?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref